chevron_leftBack
As of 24 April 2025, Haw Par Corporation Ltd. has a market cap of $2.19B USD, ranking #5041 globally and #39 in Singapore. It ranks #456 in the Healthcare sector, and #36 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$2.19BUSD
2.88B SGD
Enterprise Value
$1.65BUSD
2.17B SGD
Revenue (TTM)
$186.07MUSD
244.82M SGD
EBITDA (TTM)
$53.0MUSD
69.74M SGD
Net Income (TTM)
$173.49MUSD
228.27M SGD
EBITDA Margin
28%
Profit Margin
93%
PE Ratio
12.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ee Lim Wee
open_in_new
Employees
595
Founded
1969
Website
hawpar.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 3.3% | 0.5% | 15% | 19% | 32% |
Upcoming Earnings
Earnings Date
Fri, May 9
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
H02
Haw Par Corp Ltd
ISIN: SG1D25001158
Shares Out.:
Shares Outstanding:
221.368M1
Shares Float:
133.687M2
|
13.01 SGD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Haw Par Corporation Ltd.
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development and owning and letting properties; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.
